HIV感染孕妇产前或产后接种结合疫苗与多糖肺炎球菌疫苗的免疫原性
这项双盲研究将346名接受抗逆转录病毒治疗的HIV感染孕妇随机分为产前接种PCV-10、PPV-23或安慰剂组,产后安慰剂组再随机接种PCV-10或PPV-23。产后接种的抗体反应高于产前接种;PCV-10对7个共同血清型中4个的抗体水平低于PPV-23、对1个高于PPV-23;产前免疫产生次优抗体反应,作者认为产后加强剂量可能有益并需进一步研究。
要点
- 产后接种肺炎球菌疫苗的抗体反应高于产前接种。
- PCV-10对7个共同血清型中4个的抗体水平低于PPV-23、对1个高于PPV-23。
- 产前免疫产生次优抗体反应,作者认为产后加强剂量可能有益并需进一步研究。
核心结论
- 产前免疫产生次优抗体反应,提示产后加强剂量可能有益并需进一步研究。
- 鉴于PCV-10与PPV-23免疫原性相似但PPV-23覆盖更多血清型,作者认为接受抗逆转录病毒治疗的HIV感染女性可优先使用PPV-23。
研究设计与样本
- 双盲研究随机纳入346名接受抗逆转录病毒治疗的HIV感染孕妇,在孕14-34周随机接种PCV-10、PPV-23或安慰剂。
- 产前接受安慰剂的女性在产后24周随机接种PCV-10或PPV-23。
- 通过ELISA/化学发光法检测针对两疫苗共有的7个血清型及仅PPV-23含有的1个血清型的抗体,通过FLUOROSPOT检测针对血清型1的B细胞和T细胞反应,通过化学发光法检测血浆细胞因子/趋化因子。
主要发现
- 产后接种的抗体反应高于产前接种。
- PCV-10对7个共同血清型中4个的抗体水平低于PPV-23、对1个高于PPV-23。
- 与高疫苗接种后抗体浓度相关的其他因素包括高接种前抗体浓度和CD4+细胞、低CD8+细胞和血浆HIV RNA以及若干血浆细胞因子/趋化因子。
- 接种后血清型1的B细胞和T细胞记忆未增加。
临床怎么用
- 作者认为产后加强剂量可能有益并需进一步研究。
- 作者认为接受抗逆转录病毒治疗的HIV感染女性可优先使用PPV-23。
局限性
- 产前免疫产生次优抗体反应,提示产后加强剂量可能有益并需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pneumococcal vaccination is recommended in people with HIV, prioritizing PCV. We compared the immunogenicity of PCV-10 and PPV-23 administered antepartum or postpartum. METHODS: This double-blind study randomized 346 pregnant women with HIV on antiretrovirals to PCV-10, PPV-23, or placebo at 14-34 weeks gestational age. Women who received placebo antepartum were randomized at 24 weeks postpartum to PCV-10 or PPV-23. Antibodies against 7 serotypes common to both vaccines and 1 serotype only in PPV-23 were measured by ELISA/chemiluminescence; B- and T-cell responses to serotype 1 by FLUOROSPOT; and plasma cytokines/chemokines by chemiluminescence. RESULTS: Antibody responses were higher after postpartum versus antepartum vaccination. PCV-10 generated lower antibody levels than PPV-23 against 4 and higher against 1 of 7 common serotypes. Additional factors associated with high postvaccination antibody concentrations were high prevaccination antibody concentrations and CD4+ cells; low CD8+ cells and plasma HIV RNA; and several plasma cytokines/chemokines. Serotype 1 B- and T-cell memory did not increase after vaccination. CONCLUSIONS: Antepartum immunization generated suboptimal antibody responses, suggesting that postpartum booster doses may be beneficial and warrant further studies. Considering that PCV-10 and PPV-23 had similar immunogenicity, but PPV-23 covered more serotypes, use of PPV-23 may be prioritized in women with HIV on antiretroviral therapy. CLINICAL TRAILS REGISTRATION: NCT02717494.
引用
- Duarte G, Muresan P, Ward S, et al. Immunogenicity of Conjugated and Polysaccharide Pneumococcal Vaccines Administered During Pregnancy or Postpartum to Women With HIV. J Infect Dis. 2022. PMID: 34791324. doi:10.1093/infdis/jiab567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。